JW Holdings (096760) Fundamentals 2026 — P/E 3.8x, Revenue Analysis | SniperIQ
JW Holdings (096760) is a KR-listed Healthcare company in Drug Manufacturers - Specialty & Generic with a market capitalization of ₩262.9B, trading at ₩3800.00 on the KSC. This SniperIQ fundamentals page covers JW Holdings's valuation (P/E 3.8x, P/B 1.0x), profitability (net margin 7.1%), revenue (₩969.0B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is JW Holdings's market cap?
JW Holdings (096760) has a market capitalization of approximately ₩262.9B, trading at ₩3800.00 on the KSC. Market cap moves with the live share price.
What is JW Holdings's P/E ratio?
JW Holdings's trailing twelve-month P/E ratio is 3.8x, with a price-to-book (P/B) of 1.0x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is JW Holdings?
JW Holdings runs a net profit margin of 7.1%, a gross margin of 50.4%, and an operating margin of 18.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does JW Holdings generate?
JW Holdings reported revenue of ₩969.0B for fiscal year 2025, with net income of ₩58.5B and earnings per share (EPS) of 840.93. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does JW Holdings pay a dividend?
JW Holdings offers a trailing dividend yield of about 5.7%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is JW Holdings financially healthy?
JW Holdings carries a debt-to-equity ratio of 1.35x and a current ratio of 0.73x, with a market beta of 0.57. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is JW Holdings a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For JW Holdings (096760) the key facts are: market cap ₩262.9B, P/E 3.8x, revenue ₩969.0B, 52-week range 3145-4495. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track JW Holdings's full fundamentals live
Get JW Holdings's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.